Michael Ou, MD

Title(s)RESIDENT, Surgery
SchoolSchool of Medicine
Address35 Medical Center Way
San Francisco CA 94143
Phone415-476-1239
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Johns Hopkins University, Baltimore, MDB.S.05/2016Neuroscience
    Johns Hopkins School of Medicine, Baltimore, MDM.D.05/2022

    Collapse Overview 
    Collapse Overview
    Michael Ou is a general surgery resident at UCSF. He completed his undergraduate studies at Johns Hopkins University and medical school at Johns Hopkins School of Medicine. His interests include clinical outcomes research.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Low-volume hospitals are not associated with inferior outcomes after thoracic endovascular aortic repair. J Vasc Surg. 2022 04; 75(4):1202-1210. Alhajri N, Yin K, Locham S, Ou M, Malas MB. PMID: 34848350.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19. Transplantation. 2021 11 01; 105(11):e270-e271. Boyarsky BJ, Barbur I, Chiang TP, Ou MT, Greenberg RS, Teles AT, Krach MR, López JI, Garonzik-Wang JM, Avery RK, Massie AB, Segev DL, Werbel WA. PMID: 34284420; PMCID: PMC8549119.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    3. Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):e137-e138. Boyarsky BJ, Chiang TP, Teles AT, Greenberg RS, Krach MR, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL, Werbel AWA. PMID: 34241987; PMCID: PMC8484034.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic Health
    4. Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 10 01; 105(10):2170-2174. Ou MT, Boyarsky BJ, Motter JD, Greenberg RS, Teles AT, Ruddy JA, Krach MR, Jain VS, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. PMID: 33859151; PMCID: PMC8487696.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsPHPublic Health
    5. Antibody Response to Severe Acute Respiratory Syndrome-Coronavirus-2 Messenger RNA Vaccines in Liver Transplant Recipients. Liver Transpl. 2021 12; 27(12):1852-1856. Strauss AT, Hallett AM, Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Tobian AAR, Massie AB, Hamilton JPA, Garonzik-Wang JM, Segev DL. PMID: 34407309; PMCID: PMC8441851.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    6. Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept. Transplantation. 2021 09 01; 105(9):2119-2123. Ou MT, Boyarsky BJ, Chiang TPY, Bae S, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. PMID: 34028386; PMCID: PMC8380692.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    7. SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients. J Heart Lung Transplant. 2021 12; 40(12):1579-1588. Hallett AM, Greenberg RS, Boyarsky BJ, Shah PD, Ou MT, Teles AT, Krach MR, López JI, Werbel WA, Avery RK, Bae S, Tobian AA, Massie AB, Higgins RSD, Garonzik-Wang JM, Segev DL, Bush EL. PMID: 34456108; PMCID: PMC8349311.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    8. Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients. Transplantation. 2021 08 01; 105(8):e82-e83. Boyarsky BJ, Chiang TP, Ou MT, Werbel WA, Massie AB, Segev DL, Garonzik-Wang JM. PMID: 34098566; PMCID: PMC8298284.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsPHPublic Health
    9. Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series. Ann Intern Med. 2021 09; 174(9):1330-1332. Werbel WA, Boyarsky BJ, Ou MT, Massie AB, Tobian AAR, Garonzik-Wang JM, Segev DL. PMID: 34125572; PMCID: PMC8252023.
      View in: PubMed   Mentions: 109     Fields:    Translation:HumansCells
    10. Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine. Transplant Direct. 2021 Jul; 7(7):e713. Ou MT, Boyarsky BJ, Zeiser LB, Po-Yu Chiang T, Ruddy J, Van Pilsum Rasmussen SE, Martin J, St Clair Russell J, Durand CM, Avery RK, Werbel WA, Cooper M, Massie AB, Segev DL, Garonzik-Wang JM. PMID: 34131585; PMCID: PMC8196090.
      View in: PubMed   Mentions: 7  
    11. Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study. Transplantation. 2021 05 01; 105(5):e52-e53. Boyarsky BJ, Ou MT, Werbel WA, Avery RK, Clarke WA, Tobian AAR, Massie AB, Segev DL, Garonzik Wang JM. PMID: 33617174; PMCID: PMC8085060.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    12. Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients. Transplantation. 2021 05 01; 105(5):e56-e57. Boyarsky BJ, Ou MT, Greenberg RS, Teles AT, Werbel WA, Avery RK, Massie AB, Segev DL, Garonzik-Wang JM. PMID: 33560728; PMCID: PMC8084895.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    13. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 08; 80(8):1098-1099. Boyarsky BJ, Ruddy JA, Connolly CM, Ou MT, Werbel WA, Garonzik-Wang JM, Segev DL, Paik JJ. PMID: 33757968; PMCID: PMC8822300.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCellsPHPublic Health
    14. Anemia as an independent predictor of adverse outcomes after carotid revascularization. J Vasc Surg. 2020 11; 72(5):1711-1719.e2. Dakour-Aridi H, Ou MT, Locham S, Mathlouthi A, Farber A, Malas MB. PMID: 32249047.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Measurement of Retinal Microvascular Blood Velocity Using Erythrocyte Mediated Velocimetry. Sci Rep. 2019 12 27; 9(1):20178. Tracey BM, Mayo LN, Le CT, Chen VY, Weichsel J, Renner CY, Li J, Tsai JJ, Kalarn SP, Ou MT, Chang LY, Mohammed TK, Mohammed ISK, Shah KA, Thompson GM, Jones AMK, Im LT, Kaleem MA, Saeedi OJ. PMID: 31882799; PMCID: PMC6934793.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    16. Outcomes following Eversion versus Conventional Endarterectomy in the Vascular Quality Initiative Database. Ann Vasc Surg. 2020 May; 65:1-9. Dakour-Aridi H, Ou M, Locham S, AbuRahma A, Schneider JR, Malas M. PMID: 31626932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. A Pilot Study on the Effects of Physician Gaze on Patient Satisfaction in the Setting of Electronic Health Records. J Acad Ophthalmol. 2019 Jul; 11(2):e24-e29. Ou MT, Kleiman H, Kalarn S, Moradi A, Shukla S, Danielson M, Kaleem M, Boland M, Robin AL, Saeedi OJ. PMID: 32656491; PMCID: PMC7351322.
      View in: PubMed   Mentions:
    18. Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016 09 30; 353(6307). Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, Ge P, Umanah GE, Brahmachari S, Shin JH, Kang HC, Zhang J, Xu J, Chen R, Park H, Andrabi SA, Kang SU, Gonçalves RA, Liang Y, Zhang S, Qi C, Lam S, Keiler JA, Tyson J, Kim D, Panicker N, Yun SP, Workman CJ, Vignali DA, Dawson VL, Ko HS, Dawson TM. PMID: 27708076; PMCID: PMC5510615.
      View in: PubMed   Mentions: 250     Fields:    Translation:HumansAnimalsCells
    Michael's Networks
    Concepts (81)
    Derived automatically from this person's publications.
    _
    Co-Authors (1)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _